Clinical Trial Results:
Conversion trial from Cellcept® (MMF) to myfortic® (enteric-coated MPA) in stable transplanted patients suffering from GI adverse events while on Cellcept® therapy.
Summary
|
|
EudraCT number |
2004-001361-18 |
Trial protocol |
BE |
Global completion date |
22 Aug 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
27 Aug 2016
|
First version publication date |
27 Aug 2016
|
Other versions |
|
Summary report(s) |
CERL080ABE01.CTR.02Aug2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.